Novo Nordisk A/S
NVO
$65.77
$0.921.42%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.05B | 14.65B | 13.79B | 13.05B | 12.99B |
| Total Depreciation and Amortization | 1.32B | 1.10B | 1.18B | 1.23B | 1.10B |
| Total Amortization of Deferred Charges | 36.44M | 36.44M | 30.75M | 30.75M | 30.75M |
| Total Other Non-Cash Items | 5.37B | 3.69B | 5.52B | 2.37B | 1.35B |
| Change in Net Operating Assets | -2.80B | -1.89B | -3.31B | 56.62M | -1.84B |
| Cash from Operations | 18.98B | 17.59B | 17.21B | 16.73B | 13.62B |
| Capital Expenditure | -7.49B | -6.83B | -5.89B | -4.95B | -4.30B |
| Sale of Property, Plant, and Equipment | 4.50K | 4.50K | 147.40K | -- | -- |
| Cash Acquisitions | -11.74B | -11.74B | -96.39M | -96.39M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -814.90M | 42.96M | -1.64B | -1.42B | -537.38M |
| Cash from Investing | -20.05B | -18.53B | -7.62B | -6.47B | -4.84B |
| Total Debt Issued | 106.75B | 79.39B | 34.63B | 34.51B | -- |
| Total Debt Repaid | -18.05B | -6.34B | -6.26B | -5.99B | -1.31B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -18.73B | -20.18B | -22.45B | -26.19B | -27.56B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -7.27B | -6.45B | -6.45B | -6.12B | -6.12B |
| Other Financing Activities | 21.45B | 0.00 | 0.00 | 0.00 | 1.94B |
| Cash from Financing | 5.73B | 1.12B | -5.61B | -5.79B | -10.04B |
| Foreign Exchange rate Adjustments | 45.12M | 63.66M | -68.99M | 43.34M | 27.78M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.70B | 241.41M | 3.92B | 4.51B | -1.23B |